Vischer Henry F, Nijmeijer Saskia, Smit Martine J, Leurs Rob
Division of Medicinal Chemistry, Faculty of Sciences, Leiden/Amsterdam Center for Drug Research, VU University Amsterdam, Amsterdam, The Netherlands.
Biochem Biophys Res Commun. 2008 Dec 5;377(1):93-7. doi: 10.1016/j.bbrc.2008.09.082. Epub 2008 Sep 26.
Epstein-Barr virus (EBV) is a human herpesvirus that primarily infects B lymphocytes and is associated with tumor development. Like other herpesviruses, EBV has pirated and modified host genes encoding important regulatory cellular proteins to take over cellular control after infection. One of these genes (BILF1) encodes a G protein-coupled receptor (GPCR). It is currently accepted that GPCRs exist and function as dimers. B lymphocyte migration and functioning is regulated by chemokines acting on their cognate receptors. In this study, we show that BILF1 heterodimerizes with various chemokine receptors using BRET, trFRET and co-immunoprecipitation. Importantly, heterodimerization of BILF1 with chemokine receptors may alter the responsiveness of B lymphocytes to chemokines thereby altering homing and homeostasis of infected B lymphocytes and might be essential for EBV dissemination and/or involved in EBV-induced pathogenesis.
爱泼斯坦-巴尔病毒(EBV)是一种人类疱疹病毒,主要感染B淋巴细胞,并与肿瘤发生有关。与其他疱疹病毒一样,EBV在感染后盗用并修饰了编码重要调节细胞蛋白的宿主基因,以接管细胞控制。其中一个基因(BILF1)编码一种G蛋白偶联受体(GPCR)。目前认为GPCR以二聚体形式存在并发挥功能。B淋巴细胞的迁移和功能受作用于其同源受体的趋化因子调节。在本研究中,我们使用生物发光共振能量转移(BRET)、时间分辨荧光共振能量转移(trFRET)和免疫共沉淀表明,BILF1与多种趋化因子受体形成异源二聚体。重要的是,BILF1与趋化因子受体的异源二聚化可能会改变B淋巴细胞对趋化因子的反应性,从而改变受感染B淋巴细胞的归巢和内环境稳定,可能对EBV传播至关重要和/或参与EBV诱导的发病机制。